Maze Therapeutics (MAZE) Sof foyda bo'yicha sotuv rentabelligi

Maze Tx (MAZE) grafik logotipi

Maze Therapeutics Inc noyob genetik patologiyalarga qarshi kurashish uchun terapiyalarni ishlab chiqishga e'tibor qaratadi. Biroq, GURU.Markets ma'lumotlarida ko'rsatilganidek, yuklar bo'yicha sof foyda marjasi ulkan R&D xarajatlari va klinik sinovlarning muvaffaqiyatsiz tugash xavfi tufayli tebranishlarni namoyon etmoqda. Ushbu grafikning joriy burilish nuqtasi kichik molekulyar katalizatorlarga bo'lgan kutishlar bilan bog'liq, -757.40 esa ishlab chiqishning yuqori xarajatlarini ta'kidlagan holda, oxirgi metrika qiymatini aks ettiradi.

MAZE: Maze Therapeutics Corp Kompaniyaning sof rentabelligi 01.02.2025 - 20.11.2026

Maze Therapeutics Corp (MAZE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Maze Therapeutics, MAZE
Maze Tx yetakchi tovari

Aktivlarning qiyosiy tahlili uchun investor ushbu metrikani sof foydaning tushumga nisbati sifatida ishlatadi, bu esa sotuvlarning har bir dollari uchun haqiqiy daromad ulushini belgilaydi. GURU.Markets platformasida Maze Therapeutics Inc (MAZE) uchun sof foydaga asoslangan sotuv samaradorligi ko'rsatkichi tadqiqot va ishlanmalar (R&D) bosqichining xususiyatlarini aks ettiradi: tijorat tushumlarining yo'qligi va genomika tadqiqotlarining yuqori xarajatlari vaqtincha salbiy tendentsiyani yuzaga keltirmoqda.

Maze Therapeutics Inc kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX